The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology (한방안이비인후피부과학회지)

The Society of Korean Medicine Ophthalmology, Otolaryngology & Dermatology (대한한방안이비인후피부과학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of Ethanol Extracts of Anemarrhena asphodeloides on Skin Barrier Function by Inflammation

지모 주정 추출물이 염증으로 손상된 피부장벽 기능에 미치는 영향

  • Jeong, Mi-Rim (Department of Ophthalmology and Otolaryngology and Dermatology, College of Korean Medicine, Sangji University) ;
  • Lee, Kyou-Young (Department of Ophthalmology and Otolaryngology and Dermatology, College of Korean Medicine, Sangji University) ;
  • Hong, Chul-Hee (Department of Ophthalmology and Otolaryngology and Dermatology, College of Korean Medicine, Sangji University)
  • 정미림 (상지대학교 한의과대학 안이비인후피부과학교실) ;
  • 이규영 (상지대학교 한의과대학 안이비인후피부과학교실) ;
  • 홍철희 (상지대학교 한의과대학 안이비인후피부과학교실)
  • Received : 2018.03.27
  • Accepted : 2018.05.02
  • Published : 2018.05.25
Download PDF
⟨ Previous Next ⟩

Abstract

목적 : 본 연구에서는 $TNF-{\alpha}$와 $IFN-{\gamma}$로 자극한 인간피부각질형성세포 (HaCaT keratinocytes) 모델을 사용하여 지모가 피부장벽 기능에 미치는 영향을 알아보고자 하였다. 방법 : MTT assay를 통하여 지모 주정(70% 에탄올) 추출물 (EAA)이 HaCaT keratinocytes의 세포생존율에 미치는 영향을 확인하였으며 wound healing assay를 통해 EAA가 HaCaT 세포의 이주 능력에 영향을 주는지 관찰하였다. 또한 western blot analysis와 qRT-PCR을 통하여 EAA가 $TNF-{\alpha}/IFN-{\gamma}$로 자극한 HaCaT 세포에서 iNOS의 단백질 발현 및 IL-4, IL-13, IL-6의 mRNA 발현, filaggrin의 단백질과 mRNA 발현에 미치는 영향을 조사하였다. 결과 : EAA는 처리 농도 $500{\mu}g/ml$까지 HaCaT keratinocytes의 세포생존율에 영향을 미치지 않았다. EAA는 wound healing assay에서 HaCaT 세포의 이주 능력을 증가시켰으며, $TNF-{\alpha}/IFN-{\gamma}$로 자극한 HaCaT 세포에서 iNOS의 단백질 수준을 감소시켰다. 또한 EAA가 IL-4, IL-13, IL-6의 mRNA 발현을 억제하는 것 역시 확인할 수 있었다. 뿐만 아니라 EAA는 $TNF-{\alpha}/IFN-{\gamma}$ 자극에 의해 감소했던 filaggrin을 단백질과 mRNA 수준에서 회복시켰다. 결론 : EAA가 HaCaT 세포에서 Th2 type cytokines, pro-inflammatory cytokine의 억제와 filaggrin 회복을 통해 피부장벽 기능 손상에 대한 억제활성을 갖는 것을 확인하였으며, 이를 통해 EAA가 염증으로 인해 손상된 피부장벽 기능 개선에 효과적일 것으로 사료된다.

Keywords

References

  1. Lee SH, Jeong SK, Ahn SK. An update of the defensive barrier function of skin. Yonsei Med J. 2006;47:293-306. https://doi.org/10.3349/ymj.2006.47.3.293
  2. Strid J, Strobel S. Skin barrier dysfunction and systemic sensitization to allergens through the skin. Current drug targets. Inflammation and allergy. 2005;4(5):531-41. https://doi.org/10.2174/156801005774322199
  3. Dang NN, Pang SG, Song HY, An LG, Ma XL. Filaggrin silencing by shRNA directly impairs the skin barrier function of normal human epidermal keratinocytes and then induces an immune response. Brazilian J of medical and biological research. 2015;48(1):39-45. https://doi.org/10.1590/1414-431X20144047
  4. Furue M, Chiba T, Tsuji G, Ulzii D, Kido-Nakahara M, Nakahara T, et al. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergology international. 2016;66(3):398-403. https://doi.org/10.1016/j.alit.2016.12.002
  5. Honzke S, Wallmeyer L, Ostrowski A, Radbruch M, Mundhenk L, Schafer-Korting M, et al. Influence of Th2 Cytokines on the Cornified Envelope, Tight Junction Proteins, and ${\beta}$-Defensins in Filaggrin-Deficient Skin Equivalents. The J of investigative dermatology. 2016;136(3):631-9. https://doi.org/10.1016/j.jid.2015.11.007
  6. Yang BY, Zhang J, Liu Y, Kuang HX. Steroidal Saponins from the Rhizomes of A. asphodeloides. Molecules. 2016;21(8):1075. PMID: 27548119. https://doi.org/10.3390/molecules21081075
  7. Bak JP, Cho YM, Kim I, Park DW, Kwon JE, Jeong YJ, et al. Inhibitory effects of norlignans isolated from A. asphodeloides on degranulation of rat basophilic leukemia-2H3Cells. Biomedicine & pharmacotherapy. 2016;84:1061-6. PMID: 27780134. https://doi.org/10.1016/j.biopha.2016.10.039
  8. Chai OH, Shon DH, Han EH, Kim HT, Song CH. Effects of Anemarrhena asphodeloides on IgE-mediated passive cutaneous anaphylaxis, compound 48/80-induced systemic anaphylaxis and mast cell activation. Experimental and Toxicologic Pathology. 2013;65(4):419-26. https://doi.org/10.1016/j.etp.2011.12.006
  9. Kim HS, Song JH, Youn UJ, Hyun JW, Jeong WS, Lee MY, et al. Inhibition of UVB-induced wrinkle formation and MMP-9 expression by mangiferin isolated from Anemarrhena asphodeloides Type. European J of Pharmacology. 2012;689:38-44. https://doi.org/10.1016/j.ejphar.2012.05.050
  10. Chae SW, Piao MJ, Kang KA, et al. Inhibition of Matrix Metalloproteinase-1 Induced by Oxidative Stress in Human Keratinocytes by Mangiferin Isolated from Anemarrhena asphodeloides. Bioscience, biotechnology, and biochemistry. 2011;75(12):2321-5. https://doi.org/10.1271/bbb.110465
  11. Eisinger M, Sadan S, Silver IA, Flick RB. Growth regulation of skin cells by epidermal cell-derived factors: implications for wound healing. Proceedings of the National Academy of Sciences of the United States of America. 1988;85(6):1937-41. https://doi.org/10.1073/pnas.85.6.1937
  12. Kim MS, Lee HJ, Randy A, Yun JH, Oh SR, Nho CW. Stellera chamaejasme and its constituents induce cutaneous wound healing and anti-inflammatory activities. Scientific Reports. 2017;7(1):42490. https://doi.org/10.1038/srep42490
  13. Chartrain NA, Geller DA, Koty PP, Sitrin NF, Nussler AK, Hoffman PE, et al. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J of biological chemistry. 1994;269(9):6765.
  14. Kim BE, Leung DY, Boguniewicz M, Howell MD. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clinical immunology. 2008;126(3):332-7. https://doi.org/10.1016/j.clim.2007.11.006
  15. Park HJ, Jang YJ, Yim JH, Lee HK, Pyo S. Ramalin Isolated from Ramalina Terebrata Attenuates Atopic Dermatitis-like Skin Lesions in Balb/c Mice and Cutaneous Immune Responses in Keratinocytes and Mast Cells. Phytotherapy Research. 2016;30(12): 1978-87. https://doi.org/10.1002/ptr.5703
  16. Choi JK, Oh HM, Lee S, Park JW, Khang D, Lee SW, et al. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model. Toxicology and applied pharmacology. 2013;269(1):72-80. https://doi.org/10.1016/j.taap.2013.03.001
  17. Yang G, Cheon SY, Chung KS, Lee SJ, Hong CH, Lee KT, et al. Solanum tuberosum L. cv Jayoung Epidermis Extract Inhibits Mite Antigen-Induced Atopic Dermatitis in NC/Nga Mice by Regulating the Th1/Th2 Balance and Expression of Filaggrin. J of medicinal food. 2015;18(9):1013-21. https://doi.org/10.1089/jmf.2014.3338
  18. Rincon M, Irvin CG. Role of IL-6 in asthma and other inflammatory pulmonary diseases. International J of biological sciences. 2012;8(9):1281-90. PubMed PMID: 23136556. Pubmed Central PMCID: 3491451. https://doi.org/10.7150/ijbs.4874
  19. Son ED, Kim HJ, Kim KH, Bin BH, Bae IH, Lim KM, et al. S100A7 (psoriasin) inhibits human epidermal differentiation by enhanced IL-6 secretion through $l{\kappa}B$/NF-${\kappa}B$ signalling. Experimental dermatology. 2016;25(8):636-41. https://doi.org/10.1111/exd.13023
  20. Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, DeBenedetto A, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J of Allergy and Clinical Immunology. 2007;120(1):150-5. https://doi.org/10.1016/j.jaci.2007.04.031
  21. Souza C, de Freitas LA, Maia Campos PM. Topical Formulation Containing Beeswax-Based Nanoparticles Improved In Vivo Skin Barrier Function. AAPS PharmSciTech. 2017;18(7):2505-16. https://doi.org/10.1208/s12249-017-0737-x
  22. Michaels AS, Chandrasekaran SK, Shaw JE. Drug permeation through human skin: theory and in vitro experimental measurement. American Institute of Chemical Engineers. 1975;21:985-96. https://doi.org/10.1002/aic.690210522
  23. Addor FA1, Aoki V. Skin barrier in atopic dermatitis. Anais brasileiros de dermatologia. 2010;85(2):184-94. https://doi.org/10.1590/S0365-05962010000200009
  24. Homey B, Steinhoff M, Ruzicka T, Leung DY. Cytokines and chemokines orchestrate atopic skin inflammation. J of Allergy and Clinical Immunology. 2006;118(1):178-89. https://doi.org/10.1016/j.jaci.2006.03.047
  25. Nemes Z, Steinert PM. Bricks and mortar of the epidermal barrier. Experimental & molecular medicine. 1999;31(1):5-19. https://doi.org/10.1038/emm.1999.2
  26. De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, et al. Tight junction defects in patients with atopic dermatitis. The J of allergy and clinical immunology. 2011;127(3):773-86. https://doi.org/10.1016/j.jaci.2010.10.018
  27. Holgate ST. Epithelium dysfunction in asthma. The J of allergy and clinical immunology. 2007;120(6):1233-44. https://doi.org/10.1016/j.jaci.2007.10.025
  28. Jin LE, Chung HJ, Pyee Y, Hong JY, Joung YU, Seo EK, et al. Suppression of inducible nitric oxide synthase expression by nyasol and broussonin A, two phenolic compounds from Anemarrhena asphodeloides, through NF-${\kappa}B$ transcriptional regulation in vitro and in vivo. Chemistry & biodiversity. 2014;11(5):749-59. PMID: 24827684 https://doi.org/10.1002/cbdv.201400003
  29. Lee HY, Stieger M, Yawalkar N, Kakeda M. Cytokines and chemokines in irritant contact dermatitis. Mediators of inflammation. 2013;5:1-7.
  30. Kurahashi R, Hatano Y, Katagiri K. IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo. J of Investigative Dermatology. 2008;128(5): 1329-31. Epub 2007 Oct 25. https://doi.org/10.1038/sj.jid.5701138
  31. Dorjsembe B, Lee HJ, Kim M, Dulamjav B, Jigjid T, Nho CW. Achillea asiatica extract and its active compounds induce cutaneous wound healing. J of ethnopharmacology. 2017;206:306-14. https://doi.org/10.1016/j.jep.2017.06.006
  32. Bruch-Gerharz D, Ruzicka T, Kolb-Bachofen V. Nitric oxide in human skin: current status and future prospects. J of Investigative Dermatology. 1998;110(1):1-7. https://doi.org/10.1046/j.1523-1747.1998.00084.x
  33. Emanuela R, Garret AF. Prostaglandins and Inflammation. Arteriosclerosis, thrombosis, and vascular biology. 2011;31(5):986-1000. https://doi.org/10.1161/ATVBAHA.110.207449
  34. O’Regan GM, Sandilands A, McLean WH Irwin, Irvine AD. Filaggrin in atopic dermatitis. J of Allergy and Clinical Immunology. 2008;122(4):689-93. https://doi.org/10.1016/j.jaci.2008.08.002
  35. O'Regan GM, Irvine AD. The role of filaggrin in the atopic diathesis. Clinical and Experimental Allergy. 2010;40(7):965-72. https://doi.org/10.1111/j.1365-2222.2010.03522.x
  36. Furue M, Chiba T, Tsuji G, Ulzii D, Kido-Nakahara M, Nakahara T, et al. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergology International. 2016;66 (3):398-403. https://doi.org/10.1016/j.alit.2016.12.002

Cited by

  1. 피부과 영역에서 steroid 테이퍼링 및 남용 완화를 위한 한약 사용에 대한 고찰 vol.33, pp.3, 2018, https://doi.org/10.6114/jkood.2020.33.3.115